-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-04-01
SWTX:NSD- (USD)
COMMON STOCK | Biotechnology |
Last Closing
USD 41.88Change
-2.25 (-5.10)%Market Cap
N/AVolume
2.59M
N/A
Verdict
Values as of: 2025-04-01
COMMON STOCK | Biotechnology |
Last Closing
USD 41.88Change
-2.25 (-5.10)%Market Cap
N/AVolume
2.59MN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
VRTX | Vertex Pharmaceuticals Inc |
N/A |
USD 126.52B |
REGN | Regeneron Pharmaceuticals Inc |
N/A |
USD 69.68B |
ARGX | argenx NV ADR |
N/A |
USD 37.97B |
ALNY | Alnylam Pharmaceuticals Inc |
N/A |
USD 31.94B |
ONC | BeiGene, Ltd. |
N/A |
USD 28.70B |
RPRX | Royalty Pharma Plc |
N/A |
USD 19.31B |
SMMT | Summit Therapeutics PLC |
N/A |
USD 14.57B |
UTHR | United Therapeutics Corporatio.. |
N/A |
USD 14.37B |
INCY | Incyte Corporation |
N/A |
USD 14.22B |
MRNA | Moderna Inc |
N/A |
USD 13.74B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
SAFE:CA | Global X Equal Weight Can.. | 27.09 % | 0.00 % |
N/A |
CAD 2.65M |
HFIN:CA | Hamilton Enhanced Canadia.. | 9.82 % | 0.00 % |
N/A |
CAD 0.20B |
HFN:CA | Hamilton Canadian Financi.. | 8.87 % | 0.00 % |
N/A |
CAD 0.01B |
HLIF:CA | Harvest Canadian Equity I.. | 3.35 % | 0.00 % |
N/A |
CAD 0.12B |
CNCR | Loncar Cancer Immunothera.. | 2.69 % | 0.79 % |
N/A |
USD 8.35M |
CDEF:CA | Manulife Smart Defensive .. | 2.51 % | 0.00 % |
N/A |
CAD 1.43M |
BBP | Virtus LifeSci Biotech Pr.. | 2.16 % | 0.79 % |
N/A |
USD 0.02B |
CEW:CA | iShares Equal Weight Banc.. | 0.00 % | 0.60 % |
N/A |
CAD 0.24B |
DXM:CA | 0.00 % | 0.67 % |
N/A |
N/A | |
FIE:CA | iShares Canadian Financia.. | 0.00 % | 0.97 % |
N/A |
CAD 1.08B |
HEF:CA | 0.00 % | 0.83 % |
N/A |
N/A | |
HPR:CA | Global X Active Preferred.. | 0.00 % | 0.63 % |
N/A |
CAD 0.99B |
PR:CA | Lysander-Slater Preferred.. | 0.00 % | 1.03 % |
N/A |
CAD 0.08B |
IDNA | iShares Genomics Immunolo.. | 0.00 % | 0.00 % |
N/A |
USD 0.12B |
RODM | Hartford Multifactor Deve.. | 0.00 % | 0.31 % |
N/A |
N/A |
XMD:CA | iShares S&P/TSX Completio.. | 0.00 % | 0.61 % |
N/A |
CAD 0.27B |
BANK:CA | Evolve Canadian Banks and.. | 0.00 % | 0.39 % |
N/A |
CAD 0.38B |
BNC:CA | Purpose Canadian Financia.. | 0.00 % | 0.68 % |
N/A |
N/A |
TQCD:CA | TD Q Canadian Dividend ET.. | 0.00 % | 0.00 % |
N/A |
CAD 0.38B |
TPIF | Timothy Plan Internationa.. | 0.00 % | 0.00 % |
N/A |
USD 0.12B |
Market Performance vs. Industry/Classification (Biotechnology) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 15.91% | 89% | A- | 90% | A- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 15.91% | 89% | A- | 90% | A- | ||
Trailing 12 Months | |||||||
Capital Gain | -9.53% | 76% | C+ | 47% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -9.53% | 76% | C+ | 45% | F | ||
Trailing 5 Years | |||||||
Capital Gain | 59.42% | 83% | B | 61% | D- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 59.42% | 83% | B | 55% | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 8.55% | 60% | D- | 61% | D- | ||
Dividend Return | 8.55% | 60% | D- | 58% | F | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 55.68% | 58% | F | 34% | F | ||
Risk Adjusted Return | 15.36% | 69% | C- | 49% | F | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This stock has shown below median earnings growth in the previous 5 years compared to its sector